Samit Hirawat insider trades

Open-market stock purchases and sales by Samit Hirawat, Director at Pacira BioSciences, Inc, from SEC Form 4 filings since Jul 1, 2019.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +17%.

Recent trades

DateStockTradeValue
Jun 10, 2026PCRX Pacira BioSciences, IncBought (not open market)—
Jun 10, 2026PCRX Pacira BioSciences, IncBought (not open market)—
Jan 27, 2026PCRX Pacira BioSciences, IncBought (not open market)—

Companies traded

  • PCRX Pacira BioSciences, Inc: other filings, last Jun 10, 2026
  • BMY Bristol Myers Squibb Co: 3 buys, last Apr 25, 2025

Get free alerts when Samit Hirawat files a new trade →